Certain medications used to treat diabetes have been linked to cases of a rare, potentially deadly flesh-eating genital infection, the Food and Drug Administration announced this week. The medications affected: sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are used in the treatment of type 2 diabetes. A Wednesday release from the FDA lists more than a dozen drugs that will have to warn of the infection. Among the brand names listed: Invokana, Farxiga and Jardiance. The infection that prompted the warning is “necrotizing fasciitis of the perineum,” also called “Fournier’s gangrene.” The rare infection affects the genital region and has a mortality rate of more than 20 percent, according to a 2012 study published by ISRN Surgery and US National Library of Medicine.
or support me on Paypal via firstname.lastname@example.org